Sunday, May 6, 2012

Popular Diabetes Treatments Could Trigger Pancreatitis and Pancreatic Cancer

Popular Diabetes Drugs and Treatments May Trigger Pancreatitis and Pancreatic Cancer: Januvia Users, Janumet Users, Victoza Users, and Byetta Users Should Be Aware of Potential Risks and Consult With Their Doctors Regarding Early Detection of Pancreas Problems and Pancreatic Cancer by Texas Diabetes Drug Cancer Lawyer Jason S. Coomer

Recent studies have indicated that a growing number of popular diabetes drugs including Januvia, Janumet, Victoza, and Byetta may cause pancreas problems including Pancreatitis and Pancreatic Cancer.  Diabetics that are taking Januvia, Janumet, Victoza, or Byetta should be aware of this potential health risk and be aware of symptoms that may suggest pancreas problems.  The warning signs of pancreatitis can include: 1) Upper abdominal pain that radiates into the back. Patients may describe this as a "boring sensation" that may be aggravated by eating, especially foods high in fat. 2) Swollen and tender abdomen 3) Nausea and vomiting 4) Fever  and 5) Increased heart rate.

Januvia Users, Janumet Users, Victoza Users, and Byetta users should be aware of these symptoms as well as any symptoms of pancreatic cancer including weight loss, dark urine and clay-colored stools, back pain, and jaundice.  Unfortunately, pancreatic cancer is difficult to diagnose, and the diagnosis is often made late in the course of the disease.  Early detection of pancreatic cancer is essential and will greatly improve a person's chances of surviving the disease.  Frequent and good communication with your doctor and awareness of you body are essential.  Additionally, make sure that all health care providers are aware that you are taking or have taken Januvia, Janument, Victoza, or Byetta.



Pancreatic cancer is the fourth leading cause of cancer death for both men and women and is one of the most deadly of all types of cancer. The diabetes drugs, Januvia and Janumet, may cause an increased risk of pancreatic cancer in patients using Januvia.

Popular Diabetes Treatment Could Trigger Pancreatitis, Pancreatic Cancer, Study Suggests

"ScienceDaily (Apr. 30, 2009) — A drug widely used to treat Type 2 diabetes may have unintended effects on the pancreas that could lead to a form of low-grade pancreatitis in some patients and a greater risk of pancreatic cancer in long-term users, UCLA researchers have found."


The consumer group, Public Citizen, has filed a petition with the Food and Drug Administration (FDA) requesting that the agency immediately remove the diabetes drug, Vicoza, from the market the increasingly prescribed diabetes drug Victoza (liraglutide [rDNA origin] injection) because it puts patients at higher risk of thyroid cancer, pancreatitis, serious allergic reactions and kidney failure that outweigh any documented clinical benefits.

Consumer Group to FDA: Take Victoza off the Market

"April 20, 2012 -- Public Citizen, the Washington, D.C.-based consumer advocacy group, is petitioning the FDA to immediately remove the type 2 diabetes drug Victoza (liraglutide) from the market. The petition claims that the injectable medication puts patients at risk of thyroid cancer, pancreatitis, serious allergic reactions, and kidney failure."


The injectable diabetes drug, Byetta (Exenatide), may cause an increased risk of pancreatic cancer in patients using ByettaIf you have lost a loved one from Pancreatic Cancer or have suffered acute pancreatitis, hemorrhagic pancreatitis, accute necrotizing pancreatitis, or pancreas cancer; and have been using Byetta (Exenatide), please report the adverse action to the prescribing medical doctor as soon as possible.

Popular diabetes drugs may raise pancreatic cancer risk – USATODAY.com

When compared to other treatments, the researchers found a sixfold increase of reported cases of pancreatitis (inflammation of the pancreas) linked to patients taking Januvia or Byetta; a 2.9-fold increase in reported cases of pancreatic cancer among those taking Byetta and a 2.7-fold increase of reported pancreatic cancers among Januvia users.
Fatal Diabetes Drug Lawsuits, Fatal Pancreatic Cancer Lawsuits, Diabetes Drug Cancer Lawsuits, and Diabetes Drug Pancreas Cancer Lawsuits

Drug manufacturers that were aware of their diabetes drug causing an increased risk of pancreatic cancer, pancreatitis, and pancreas cancer, but hid research linking this health risk can potentially be held liable by persons that have suffered pancreatitis and pancreatic cancer as well as the families of persons that have died from pancreatic cancer, pancreas cancer, thyroid cancer, or other cancers after using the drug.

The loss of a spouse, child, parent, or loved one to pancreatic cancer, pancreas cancer, or thyroid cancer can be devastating.  It is often worse to then find out that the loss of your loved one was unnecessary and could have been prevented if the defective diabetes drug manufacturer had properly disclosed the drug's potential dangers.  In these situations, where a loved one is lost from taking a defective diabetes drug and the drug company knew of the dangers of the drug, but marketed the diabetes drug as safe to make a profit; families are needed to stand up and make sure that the drug company does not get away with this and will not repeat this action to other families.

In fatal cancer diabetes drug lawsuits, diabetes drug attorneys will often work with families to seek compensation for the loss of their loved one.  Though no amount of money will ever replace or bring back their loved one.  The family will often need compensation to replace the lost earnings of their loved one or to pay medical expenses caused by the care needed by their lost loved one.   The fatal diabetes drug lawsuit will usually seek several elements of damages for the family of the deceased including their loss of love, companionship, comfort, assistance, protection, affection and care; the loss of financial support and lost benefits from the death; and loss of inheritance from an untimely death.  These fatal cancer diabetes drug lawsuits will also often include claims for what the decedent would have recovered had the person survived the cancer caused by the drug. These claims are through the decedent's estate and either go to their heirs or beneficiaries depending if the person had done any estate planning. These damages include expenses associated with the death including funeral costs, medical expenses prior to the death, and pain and suffering associated with the untimely death.  

No comments:

Post a Comment